Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Quick Specs Form: Lyophilized powder (white to off-white) Purity: 99% by HPLC every batch Identity: MS molecular-weight confirmed every batch CAS Number: 2381089-83-2 Also Known As: LY3437943, triple incretin agonist Sequence Length: 39 amino acids Molecular Formula: C228H350N48O66 (confirm per COA) Molecular Weight: ~4731 Da (confirm per COA) Receptor Targets: GIPR + GLP-1R + GCGR Modification: Fatty-diacid side chain (albumin binding) Half-Life: ~6 days (research literature) Peptide Type: Synthetic triple incretin receptor agonist COA: Janoshik third-party publicly verifiable Manufacture: Lyophilized & QC-released in-house Storage: 20C sealed | 28C reconstituted Shelf Life: 24 months unopened (lyophilized) Certificate of Analysis Janoshik ThirdParty Verification Every batch is independently tested by Janoshik
Some researchers also find that taking their dose on a day when they can rest (like Friday evening or Saturday morning) allows recovery time before the work week
El frmaco se conoce como triple agonista, lo que significa que acta sobre tres receptores diferentes en el cerebro y en todo el organismo
Dose Escalation GLP-1 medications are typically introduced at a low dose and increased gradually
The transformative weight loss effects of Semaglutide GLP-1 are similar to those typically achieved through surgical interventions, providing patients with a non-surgical option that offers substantial benefits
